Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

ADMA Biologics (ADMA) Short Interest Ratio & Short Volume

ADMA Biologics logo
$8.38 +0.11 (+1.33%)
Closing price 05/18/2026 04:00 PM Eastern
Extended Trading
$8.40 +0.02 (+0.30%)
As of 08:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ADMA Biologics Short Interest Overview

As of April 30, 2026, ADMA Biologics (ADMA) had a short interest of 20.66 million shares sold short, representing 9.03% of the public float. This marks a 7.00% increase in short interest since the prior report. The short interest ratio (days to cover) is 3.2, meaning it would take 3.2 days of the average trading volume of 7.31 million shares to cover all short positions.

Current Short Interest
20,658,114 shares
Previous Short Interest
19,306,519 shares
Change Vs. Previous Month
7.00%
Dollar Volume Sold Short
$211.75 million
Short Interest Ratio
3.2 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
231,770,000 shares
Short Percent of Float
9.03%
Today's Trading Volume
3,351,540 shares
Average Trading Volume
7,309,098 shares
Today's Volume Vs. Average
46%
Short Selling ADMA Biologics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for ADMA Biologics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ADMA Short Interest Over Time

ADMA Days to Cover Over Time

ADMA Percentage of Float Shorted Over Time

ADMA Biologics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202620,658,114 shares $211.75 million +7.0%9.0%3.22 $10.25
4/15/202619,306,519 shares $205.61 million -12.9%8.4%3.84 $10.65
3/31/202622,175,506 shares $199.80 million -14.1%9.6%1.64 $9.01
3/13/202625,826,838 shares $391.28 million +35.0%11.3%7.12 $15.15
2/27/202619,137,458 shares $297.97 million -9.1%8.3%5.72 $15.57
2/13/202621,049,574 shares $338.69 million +8.3%9.2%11.75 $16.09
1/30/202619,439,065 shares $336.30 million +4.7%8.5%9.19 $17.30
1/15/202618,573,160 shares $325.03 million -2.1%8.1%7.22 $17.50
12/31/202518,972,317 shares $346.06 million +0.8%8.3%9.32 $18.24
12/15/202518,829,424 shares $371.50 million +1.4%8.2%7.26 $19.73
11/28/202518,563,031 shares $366.25 million -0.4%8.1%5.87 $19.73
11/14/202518,629,225 shares $289.87 million +11.9%8.1%4 $15.56
10/31/202516,649,924 shares $257.74 million -5.2%7.2%5.55 $15.48
10/15/202517,560,000 shares $264.98 million +0.9%7.6%5.2 $15.09
9/30/202517,410,000 shares $255.23 million +10.6%N/A5.4 $14.66
9/15/202515,740,000 shares $240.82 million +5.1%N/A5 $15.30
8/31/202514,980,000 shares $258.55 million +0.1%6.5%4.6 $17.26
8/15/202514,960,000 shares $254.17 million +8.9%N/A5 $16.99
7/31/202513,740,000 shares $256.94 million -5.0%6.0%4.2 $18.70
7/15/202514,470,000 shares $260.17 million -10.9%N/A4.5 $17.98
6/30/202516,240,000 shares $295.73 million +17.6%7.0%4.6 $18.21
6/15/202513,810,000 shares $287.39 million -3.5%6.0%4 $20.81
5/31/202514,310,000 shares $285.77 million +7.4%6.3%4.1 $19.97
5/15/202513,330,000 shares $255.94 million +7.9%5.9%3.7 $19.20
4/30/202512,350,000 shares $293.93 million -6.9%N/A3.6 $23.80
4/15/202513,260,000 shares $293.71 million +2.3%5.8%4.4 $22.15
3/31/202512,960,000 shares $257.13 million -14.0%5.7%4.6 $19.84
3/15/202515,070,000 shares $277.74 million +5.9%6.6%5.6 $18.43
2/28/202514,230,000 shares $233.23 million +3.6%6.3%5.8 $16.39
2/15/202513,740,000 shares $218.47 million +4.3%6.0%5.8 $15.90
1/31/202513,180,000 shares $212.86 million -2.6%N/A4.9 $16.15
1/15/202513,530,000 shares $226.09 million -0.7%N/A4.6 $16.71
12/31/202413,620,000 shares $233.58 million +11.8%N/A3.9 $17.15
12/15/202412,180,000 shares $226.43 million -5.7%N/A3.2 $18.59
11/30/202412,910,000 shares $259.62 million -9.3%N/A2.6 $20.11
11/15/202414,240,000 shares $271.13 million -6.3%N/A2.8 $19.04
10/31/202415,200,000 shares $247.91 million -5.4%N/A2.9 $16.31
10/15/202416,070,000 shares $266.44 million -5.9%N/A3.1 $16.58
9/30/202417,080,000 shares $341.43 million +37.5%N/A3.6 $19.99
9/15/202412,420,000 shares $224.68 million +30.7%N/A2.6 $18.09
The Iran War Just Broke the Gold Market (Ad)

The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.tc pixel

You can see the evidence — and the ticker symbol — here >>>
8/31/20249,500,000 shares $164.45 million +5.3%N/A2.6 $17.31
8/15/20249,020,000 shares $158.66 million +3.1%N/A2.6 $17.59
7/31/20248,750,000 shares $107.45 million +5.7%N/A2.5 $12.28
7/15/20248,280,000 shares $110.87 million +13.9%N/A2.6 $13.39
6/30/20247,270,000 shares $81.28 million -23.0%N/A2.5 $11.18
6/15/20249,440,000 shares $100.35 million +2.5%N/A3.4 $10.63
5/31/20249,210,000 shares $87.96 million +9.1%N/A3.3 $9.55
5/15/20248,440,000 shares $76.80 million -3.2%N/A2.9 $9.10
4/30/20248,720,000 shares $56.85 million +7.5%N/A3.4 $6.52
4/15/20248,110,000 shares $48.50 million +11.3%N/A3.2 $5.98
3/31/20247,290,000 shares $48.11 million -8.8%N/A2.7 $6.60
3/15/20247,990,000 shares $47.86 million +18.9%N/A3 $5.99
2/29/20246,720,000 shares $36.02 million +9.3%N/A2.6 $5.36
2/15/20246,150,000 shares $33.21 million -10.1%N/A2.9 $5.40
1/31/20246,840,000 shares $35.50 million -14.8%N/A3.2 $5.19
1/15/20248,030,000 shares $40.07 million +19.0%N/A3.7 $4.99
12/31/20236,750,000 shares $30.51 million -13.6%N/A3.4 $4.52
12/15/20237,810,000 shares $32.80 million -10.2%N/A4.2 $4.20
11/30/20238,700,000 shares $32.19 million -6.3%N/A4.9 $3.70
11/15/20239,280,000 shares $35.26 million -3.1%N/A4.8 $3.80
10/31/20239,580,000 shares $32.38 million +3.9%N/A4.1 $3.38
10/15/20239,220,000 shares $29.60 million +3.3%N/A4.2 $3.21
9/30/20238,930,000 shares $31.97 million +2.8%N/A4.1 $3.58
9/15/20238,690,000 shares $32.41 million -1.9%N/A4.1 $3.73
8/31/20238,860,000 shares $34.11 million -1.7%N/A4 $3.85
8/15/20239,010,000 shares $40.91 million +8.4%N/A4.2 $4.54
7/31/20238,310,000 shares $34.49 million -2.4%N/A4.1 $4.15
7/15/20238,510,000 shares $30.38 million +2.7%N/A4.2 $3.57
6/30/20238,290,000 shares $30.59 million -19.8%N/A3.9 $3.69
6/15/202310,340,000 shares $41.26 million -1.2%N/A4.6 $3.99
5/31/202310,460,000 shares $42.57 million -6.4%N/A4.4 $4.07
5/15/202311,170,000 shares $46.80 million -1.2%N/A4.6 $4.19
4/30/202311,310,000 shares $37.89 million -2.8%N/A5.1 $3.35
4/15/202311,640,000 shares $37.02 million -6.8%N/A4.9 $3.18
3/31/202312,490,000 shares $41.34 million +14.4%N/A5.1 $3.31
3/15/202310,920,000 shares $34.18 million +0.8%N/A4.4 $3.13
2/28/202310,830,000 shares $38.45 million -6.2%N/A3.8 $3.55
2/15/202311,550,000 shares $41.35 million -9.7%N/A3.9 $3.58
1/31/202312,790,000 shares $47.20 million +6.1%N/A3.8 $3.69
1/15/202312,050,000 shares $40.97 million -5.3%N/A3.7 $3.40
12/30/202212,720,000 shares $49.35 million +1.8%N/A4 $3.88
12/15/202212,500,000 shares $44.50 million -37.4%N/A3.7 $3.56
11/30/202219,980,000 shares $66.73 million -8.1%N/A6 $3.34
11/15/202221,740,000 shares $70.44 million -15.9%N/A7.2 $3.24
10/31/202225,860,000 shares $72.93 million +0.2%N/A9.1 $2.82
10/15/202225,820,000 shares $67.65 million -6.3%N/A9.5 $2.62
9/30/202227,560,000 shares $66.97 million +6.0%N/A10.4 $2.43
9/15/202225,990,000 shares $70.43 million -2.0%N/A9 $2.71
8/31/202226,520,000 shares $71.60 million -6.2%N/A9.8 $2.70
8/15/202228,270,000 shares $68.13 million -1.7%N/A10.7 $2.41
I was right about SpaceX (Ad)

Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel

See how to claim your stake in SpaceX before the public can
7/31/202228,760,000 shares $61.55 million +0.1%N/A11.1 $2.14
7/15/202228,730,000 shares $66.08 million +1.3%N/A10.2 $2.30
6/30/202228,360,000 shares $56.15 million +11.0%N/A9.8 $1.98
6/15/202225,540,000 shares $51.85 million +1.0%N/A8.1 $2.03
5/31/202225,300,000 shares $51.87 million +5.4%N/A9.3 $2.05
5/15/202224,010,000 shares $42.26 million +4.5%N/A9.2 $1.76
4/30/202222,980,000 shares $42.28 million +3.1%N/A9.1 $1.84
4/15/202222,300,000 shares $44.82 million +10.1%N/A9.3 $2.01
3/31/202220,250,000 shares $37.06 million +25.0%N/A8.8 $1.83
3/15/202216,200,000 shares $25.11 million +10.7%N/A8.2 $1.55
2/28/202214,640,000 shares $23.57 million +4.4%N/A7.4 $1.61
2/15/202214,020,000 shares $23.41 million +36.0%N/A7.2 $1.67
1/31/202210,310,000 shares $14.95 million +1.2%N/A4.6 $1.45
1/15/202210,190,000 shares $14.27 million -4.1%N/A4.5 $1.40
12/31/202110,620,000 shares $14.97 million +6.6%N/A4.1 $1.41
12/15/20219,960,000 shares $12.75 million -1.2%N/A4 $1.28
11/30/202110,080,000 shares $13.91 million -9.7%N/A4.1 $1.38
11/15/202111,160,000 shares $17.30 million -7.4%N/A3.5 $1.55
10/29/202112,050,000 shares $15.54 million +4.4%N/A3.5 $1.29
10/15/202111,540,000 shares $12.69 million +10.5%N/A3.5 $1.10
9/30/202110,440,000 shares $11.80 million -9.9%8.3%3.6 $1.13
9/15/202111,590,000 shares $13.91 million -5.2%9.2%3.7 $1.20
8/31/202112,220,000 shares $16.37 million -3.3%9.7%3.9 $1.34
8/13/202112,640,000 shares $18.83 million -5.1%10.0%4.9 $1.49
7/30/202113,320,000 shares $20.65 million +14.2%10.6%6.3 $1.55
7/15/202111,660,000 shares $17.26 million +14.8%9.2%1.8 $1.48
6/30/202110,160,000 shares $16.26 million -16.9%8.1%1.5 $1.60
6/15/202112,220,000 shares $21.75 million +11.4%9.7%1.8 $1.78
5/28/202110,970,000 shares $19.20 million -0.6%8.7%1.6 $1.75

ADMA Short Interest - Frequently Asked Questions

Short interest is the volume of ADMA Biologics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 20,658,114 shares of ADMA short. 9.03% of ADMA Biologics' shares are currently sold short. Learn More on ADMA Biologics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADMA shares currently have a short interest ratio of 3.2. Learn More on ADMA Biologics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ADMA Biologics: Millennium Management LLC, Caption Management LLC, and 683 Capital Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.03% of ADMA Biologics' floating shares are currently sold short.

ADMA Biologics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 20,658,114 shares, an increase of 7.0% from the previous total of 19,306,519 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

9.03% of ADMA Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ADMA Biologics: ACADIA Pharmaceuticals Inc. (8.83%), Allogene Therapeutics, Inc. (17.34%), Vaxcyte, Inc. (10.11%), Qiagen N.V. (3.39%), Kymera Therapeutics, Inc. (14.02%), Protagonist Therapeutics, Inc. (12.37%), Spyre Therapeutics, Inc. (16.69%), Mirum Pharmaceuticals, Inc. (17.89%), Rhythm Pharmaceuticals, Inc. (12.49%), Lantheus Holdings, Inc. (8.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling ADMA is an investing strategy that aims to generate trading profit from ADMA Biologics as its price is falling. ADMA shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ADMA Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMA, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ADMA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ADMA) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Is the SpaceX IPO “Rigged?”
The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...
The Oxford Club | Sponsoredtc pixel